PIK3CA and neoplasm: Gene expression profile analysis of paired pre-treatment and on-treatment tumor samples, collected from patients treated with alpelisib as a single agent or in combination with an aromatase inhibitor, has shown that ESR1 and its target gene PGR are among the most highly induced genes upon PI3K inhibition.